Concepedia

Yen‐Chun Lee

YL

Statistics

Publications

13

Citations

413

H-Index

12

Active since

2004

Affiliations

Massachusetts Institute of Technology(Current)

National Health Research Institutes

Broad Institute

Max Planck Institute of Molecular Physiology

Harvard University

Yen‐Chun Lee is an author at Massachusetts Institute of Technology specializing in drug discovery, pharmacy, and medicinal chemistry.

ORCID

Publications per year

2004–2024

13

Publications

13

<i>De Novo</i> Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein

Sebastian Pomplun, Muhammad Jbara, Anthony J. Quartararo et al. · ACS Central Science · 2020 · 92 citations · Full text

, , +17

A ligand-directed divergent catalytic approach to establish structural and functional scaffold diversity

Yen‐Chun Lee, Sumersing Patil, Christopher Golz et al. · Nature Communications · 2017 · 67 citations · Full text

, , +17

Mirror-image ligand discovery enabled by single-shot fast-flow synthesis of D-proteins

Alex J. Callahan, Satish Gandhesiri, Tara L. Travaline et al. · Nature Communications · 2024 · 47 citations · Full text

, , +15

A Platinum(IV) Prodrug—Perfluoroaryl Macrocyclic Peptide Conjugate Enhances Platinum Uptake in the Brain

Colin M. Fadzen, Justin M. Wolfe, Wen Zhou et al. · Journal of Medicinal Chemistry · 2020 · 40 citations · Full text

, , +17

Gold(I) Catalyzed Enyne Cycloisomerization – A Roadmap to Privileged Heterocyclic Scaffolds

Yen‐Chun Lee, Kamal Kumar · Israel Journal of Chemistry · 2018 · 30 citations

, , +16

1–5 of 13